Placed on the Union Calendar, Calendar No. 296.
The bill directs the Secretary of Veterans Affairs to establish a three-year pilot program providing hyperbaric oxygen therapy (HBOT) to veterans with traumatic brain injury (TBI) or post-traumatic stress disorder (PTSD) through providers described in 38 U.S.C. 1703(c)(5). The program will operate in two Veterans Integrated Service Networks, require accreditation for participating facilities, and be funded only by donations placed into a designated VA HBOT Fund.
Evidence certainty: left sees hopeful but wants strong proof; right doubts efficacy.
Narrow, time-limited veterans health pilot with no mandatory spending typically attracts bipartisan support in the House.
The bill directs the Secretary of Veterans Affairs to establish a three-year pilot program providing hyperbaric oxygen therapy (HBOT) to veterans with traumatic brain injury (TBI) or post-traumatic stress disorder (PTSD) through providers described in 38 U.S.C. 1703(c)(5).
The program will operate in two Veterans Integrated Service Networks, require accreditation for participating facilities, and be funded only by donations placed into a designated VA HBOT Fund.
The bill defines HBOT by FDA approval or investigational device exemption, requires a GAO update on relevant clinical research within one year, and amends 38 U.S.C. 5503(d)(7) to change a statutory date from November 30, 2031 to October 30, 2034.
Limited scope, sunset, no mandatory funding, accreditation and GAO review make enactment plausible absent significant policy objections.
How solid the drafting looks.
Evidence certainty: left sees hopeful but wants strong proof; right doubts efficacy.
These are examples from the analysis, not a ranked list of the most-affected groups.
Evidence certainty: left sees hopeful but wants strong proof; right doubts efficacy.
Generally supportive of expanding veteran treatment options and research, while expecting rigorous oversight.
Concerns focus on evidence strength and reliance on donations for funding.
Cautiously supportive of a limited, evaluated pilot with accreditation and GAO oversight.
Wants clearer funding, evaluation metrics, and selection rationale for VISNs.
Moderately receptive to veteran-focused innovation, appreciating the pilot's limited scope and donor funding.
Skeptical about clinical effectiveness and expansion of VA services based on weak evidence.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Limited scope, sunset, no mandatory funding, accreditation and GAO review make enactment plausible absent significant policy objections.
The bill has not accumulated any surfaced votes yet.
Evidence certainty: left sees hopeful but wants strong proof; right doubts efficacy.
Limited scope, sunset, no mandatory funding, accreditation and GAO review make enactment plausible absent significant policy objections.
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Veterans National Traumatic Brain Injury Treatment Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.